about
Relationship between vagal tone, cortisol, TNF-alpha, epinephrine and negative affects in Crohn's disease and irritable bowel syndromeTherapeutic perspectives for melatonin agonists and antagonists.Vagal tone: effects on sensitivity, motility, and inflammation.Vagus nerve stimulation: a new promising therapeutic tool in inflammatory bowel disease.Uncertainty in anticipation of uncomfortable rectal distension is modulated by the autonomic nervous system--a fMRI study in healthy volunteers.The link between negative affect, vagal tone, and visceral sensitivity in quiescent Crohn's disease.Anti-inflammatory properties of the vagus nerve: potential therapeutic implications of vagus nerve stimulation.The Vagus Nerve in the Neuro-Immune Axis: Implications in the Pathology of the Gastrointestinal Tract.The Place of Stress and Emotions in the Irritable Bowel Syndrome.Long term effects of low frequency (10 hz) vagus nerve stimulation on EEG and heart rate variability in Crohn's disease: a case report.Brain responses to uncertainty about upcoming rectal discomfort in quiescent Crohn's disease - a fMRI study.Chronic vagus nerve stimulation in Crohn's disease: a 6-month follow-up pilot study.Nycthemeral variations of cholecystokinin action on intestinal motility in rats: effects of melatonin and S 20928, a melatonin receptor antagonist.Reversed bowel segments for the treatment of short bowel syndrome: assessment of their minimal length in correlation with electromyographic pattern in the rat.Peripheral neurotensin participates in the modulation of pre- and postprandial intestinal motility in rats.Electroencephalographic correlates of low-frequency vagus nerve stimulation therapy for Crohn's disease.The Vagus Nerve at the Interface of the Microbiota-Gut-Brain Axis.Vagus Nerve Stimulation at the Interface of Brain-Gut InteractionsEffect of melatonin on motility pattern of small intestine in rats and its inhibition by melatonin receptor antagonist S 22153Oxyntomodulin and glicentin are potent inhibitors of the fed motility pattern in small intestineToward a definition of a global psycho-physiological criterion of vulnerability to relapse in inflammatory bowel diseasesEmotional overactivity in patients with irritable bowel syndromeThe Impact of Priming on Speed Reduction on a Ski SlopeImportance of considering interoceptive abilities in alexithymia assessment
P50
Q34160082-08F13811-8E9E-4999-8C0F-7DB05259A123Q35080150-BDC9A4A3-BABC-423A-89FA-1F29398780D3Q38787059-6897DEAD-FFE3-4BB5-9722-F8BBB8B1F698Q39250092-30F6FCB0-A8F4-44A3-BC42-7BB52BDD3747Q41723582-6334704D-D7CE-4E73-878E-8200AAADC5E3Q43564722-1246AB1B-288D-4C8B-A1AB-327DB16E82AFQ44449819-369F1DDA-388F-443A-A17F-381DB45D93DAQ45040278-DE5C23EE-654F-44B2-AEDD-AACAD1FC05B9Q47356191-7B5A5E8D-6B72-4278-AE13-F4D85126E8DAQ48509362-8291833C-F2CC-4506-945B-0CEDF951712CQ48778691-B8056F6C-5FD4-4CDF-A265-4A67BCF2A9F8Q48875226-D76E039B-99B3-4F1A-BDCE-9950B90768D8Q51551467-3025EF2C-5080-48F0-94D2-89EAB15DA1CCQ51557381-0507155A-8653-4DBB-840F-9DEC0552BC15Q51579142-02F9C7A8-CCF5-4C6B-B12C-23FFB916E4C5Q52638536-957B54F3-FFA2-47DD-B5F4-75FA2EF4914FQ54269133-FEED7FB3-A625-4A71-AC91-FA7CF693079FQ57158850-B01B1455-A67A-4669-A9D3-772F567D0958Q74300944-5B8B8EB4-A519-4B18-93AD-555742CE7C51Q80440570-7655345B-A6EB-4CA1-A60F-7677BB3D60D2Q84353231-6CBFF5CD-A0AA-47BE-90B6-D8F99F0C8299Q88947202-494E3885-886D-414E-822C-44B65C83903CQ91015505-9B56CEAB-1FF7-4EDD-A209-5245BFC9A137Q91453799-AB199FED-0E8F-4CC5-A554-830769977A2C
P50
description
researcher
@en
wetenschapper
@nl
name
S Pellissier
@en
S Pellissier
@nl
type
label
S Pellissier
@en
S Pellissier
@nl
prefLabel
S Pellissier
@en
S Pellissier
@nl
P106
P31
P496
0000-0002-0033-2561